Latest Hot flash Stories
PHOENIX, Oct. 3, 2012 /PRNewswire-USNewswire/ -- Estrogen/progesterone treatment started soon after menopause appears safe and relieves many of the symptoms menopausal women face as well as improving mood and markers of cardiovascular risk, according to a multicenter randomized study presented at the North American Menopause Society (NAMS) Annual Meeting in Orlando, Florida. "The KEEPS provides invaluable information for women close to menopause and their clinicians," said S....
MENLO PARK, Calif., Oct. 3, 2012 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) announced today that it is presenting two abstracts from its Phase 3 clinical trial, BREEZE 3, at this week's 23(rd) Annual Meeting of the North American Menopause Society (NAMS) in Orlando, FL. The data showed that Serada(®), Depomed's investigational non-hormonal extended-release formulation of gabapentin, may help manage menopausal hot flashes. "Hot flashes are a disruptive problem affecting as many as...
MIAMI, FL, NEW YORK, NY and ORLANDO, FL, Oct. 3, 2012 /PRNewswire/ -- Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced positive results from two multicenter, double-blind, randomized, placebo-controlled Phase 3 clinical studies evaluating low-dose mesylate salt of paroxetine (LDMP; 7.5 mg/day) for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause. Menopausal VMS, which comprise hot...
CROMWELL, Conn., Oct. 1, 2012 /PRNewswire/ -- Every three minutes, a woman is diagnosed with breast cancer in this country, creating an abundant need to do more to find a cure.+ Estroven, the safe multi-symptom menopause relief solution, is inviting women across the country to band together during National Breast Cancer Awareness Month by "Sleeping Pink" - hosting pink-themed parties - to raise much-needed funds for the Avon Walk for Breast Cancer series, a project of the Avon...
SANTA FE, N.M., Oct. 1, 2012 /PRNewswire/ -- This story is a comparative analysis of the untold story of certain botanicals for Menopause, what risks they suggest, but most importantly, what the sellers are not telling women about the risks when they take these botanicals for Menopause, and not explaining why these ingredients do not have warning labels. Menopause affects 45 million women annually. Huge numbers! The story launched into the public four weeks ago via...
BEVERLY HILLS, Calif., Sept. 28, 2012 /PRNewswire/ -- Eaton Scientific Systems, Ltd. ("Eaton" or the "Company") a wholly owned subsidiary of Pristine Solutions, Inc. (OTCQB: PRTN) is pleased to provide this update on the current business and growth strategy of the Company. Eaton CEO, Mr. Michael Borkowski stated "Our Company was founded in 2005 in Los Angeles, CA to develop and effectuate a commercialization of Tropine 3, its novel indication of the drug homatropine in an oral...
BEVERLY HILLS, Calif., Sept. 26, 2012 /PRNewswire/ -- Eaton Scientific Systems, Ltd. ("Eaton" or the "Company") a wholly-owned subsidiary of Pristine Solutions, Inc. (OTCQB: PRTN) is pleased to highlight the increasing international potential of Tropine 3 for the non-hormonal treatment for pre-menopausal, peri-menopausal, and post-menopausal women experiencing hot flashes. "Menopause affects women all over the world, but according to recent research it actually appears to affect...
BEVERLY HILLS, Calif., Sept. 25, 2012 /PRNewswire/ --Eaton Scientific Systems, Ltd. ("Eaton" or the "Company") a wholly-owned subsidiary of Pristine Solutions, Inc. (OTCQB: PRTN) is pleased provide this outline of the market potential of Tropine 3 for the non-hormonal treatment for pre-menopausal, peri-menopausal, and post-menopausal women experiencing hot flashes. "Menopause and the effects of hot flashes in particular are without a doubt one of the most significantly important...
BEVERLY HILLS, Calif., Sept. 24, 2012 /PRNewswire/ -- Eaton Scientific Systems, Ltd. ("Eaton" or the "Company") a wholly-owned subsidiary of Pristine Solutions, Inc. (OTCQB: PRTN) is pleased to announce that Company advisor and advocate Jennifer R. Berman, MD will appear on the popular CBS Daytime TV talk show "The Talk." Taping is scheduled for September 26, 2012, to discuss women's health issues related to menopause, hot flashes and sex. Also appearing on the show is renowned...
DALLAS, Sept. 21, 2012 /PRNewswire/ -- Hot flashes, vaginal dryness and night sweats, oh my! Comedic actresses Sherri Shepherd and Cloris Leachman are finding the humor in menopause by headlining the Poise brand's Hot Flash Road Show, a free comedy tour making stops in New York and Los Angeles this fall. Open to the public, the Hot Flash Road Show is part of The 2nd Talk (www.The2ndTalk.com), an effort led by the Poise brand to start a whole new way to talk about menopause and help...
